Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters

Neurosci Lett. 2006 Jul 10;402(1-2):62-5. doi: 10.1016/j.neulet.2006.03.059. Epub 2006 Apr 19.

Abstract

The aim of our present study was to determine whether exogenous L-DOPA-derived extracellular dopamine (DA) in the denervated striatum is taken up via serotonin (5-HT) transporters. Rats with dopaminergic denervation by 6-hydroxydopamine were injected with L-DOPA 50 mg/kg (i.p.) and extracellular DA levels in the denervated striatum were measured using in vivo microdialysis technique. During the experiments, fluoxetine, a selective serotonin reuptake inhibitor, was locally perfused into the striatum through the microdialysis probe. Cumulative amounts of L-DOPA-derived extracellular DA during 300 min were increased by fluoxetine dose-dependently (10 microM and 50 microM). These results suggest that reuptake of DA via 5-HT transporters plays an important role in the clearance of L-DOPA-derived DA from the extracellular space when dopaminergic neurons are extensively denervated.

Publication types

  • Comparative Study

MeSH terms

  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Animals
  • Corpus Striatum / drug effects*
  • Dopamine / metabolism*
  • Dopamine Agents / pharmacology
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Extracellular Fluid / drug effects
  • Extracellular Fluid / metabolism*
  • Fluoxetine / pharmacology
  • Homovanillic Acid / metabolism
  • Levodopa / pharmacology*
  • Male
  • Rats
  • Rats, Wistar
  • Selective Serotonin Reuptake Inhibitors / pharmacology
  • Serotonin Plasma Membrane Transport Proteins / physiology*

Substances

  • Dopamine Agents
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Uptake Inhibitors
  • Fluoxetine
  • 3,4-Dihydroxyphenylacetic Acid
  • Levodopa
  • Dopamine
  • Homovanillic Acid